PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian journal of andrology, 2014 - journals.lww.com
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models

A Carnero, JM Paramio - Frontiers in oncology, 2014 - frontiersin.org
When PI3K (phosphatidylinositol-3 kinase) is activated by receptor tyrosine kinases, it
phosphorylates PIP2 to generate PIP3 and activates the signaling pathway. Phosphatase …

Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch

JB Tennakoon, Y Shi, JJ Han, E Tsouko, MA White… - Oncogene, 2014 - nature.com
Prostate cancer is the most commonly diagnosed malignancy among men in industrialized
countries, accounting for the second leading cause of cancer-related deaths. Although we …

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

C Chang, SO Lee, S Yeh, TM Chang - Oncogene, 2014 - nature.com
The androgen receptor (AR) is expressed in many cell types and the androgen/AR signaling
has been found to have important roles in modulating tumorigenesis and metastasis in …

Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin

OJ Kwon, L Zhang, MM Ittmann… - Proceedings of the …, 2014 - National Acad Sciences
Chronic inflammation has been shown to promote the initiation and progression of diverse
malignancies by inducing genetic and epigenetic alterations. In this study, we investigate an …

[HTML][HTML] Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities

P Toren, A Zoubeidi - International journal of oncology, 2014 - spandidos-publications.com
Abstract The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In
prostate cancer, the activation of this pathway appears to be characteristic of many …

Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway

S Shukla, N Bhaskaran, MA Babcook, P Fu… - …, 2014 - academic.oup.com
Forkhead box O (FoxO) transcription factors play an important role as tumor suppressor in
several human malignancies. Disruption of FoxO activity due to loss of phosphatase and …

Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growth

E Tsouko, AS Khan, MA White, JJ Han, Y Shi… - Oncogenesis, 2014 - nature.com
Cancer cells display an increased demand for glucose. Therefore, identifying the specific
aspects of glucose metabolism that are involved in the pathogenesis of cancer may uncover …

Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression

AJ Garcia, M Ruscetti, TL Arenzana… - … and cellular biology, 2014 - Am Soc Microbiol
Chronic inflammation is known to be associated with prostate cancer development, but how
epithelium-associated cancer-initiating events cross talk to inflammatory cells during …

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

L Chang, PH Graham, J Hao, J Bucci, PJ Cozzi… - Cancer and Metastasis …, 2014 - Springer
Radiation therapy (RT) continues to be one of the most popular treatment options for
localized prostate cancer (CaP). Local CaP recurrence after RT is a pattern of treatment …